Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AMC Entertainment (NYSE: AMC ) and GameStop (NYSE: GME ) are taking a beating today and traders of the meme stocks are reacting on social media. Source: Tero Vesalainen / Shutterstock.com AMC stock is co...
Gainers: Nuverra Environmental Solutions (NYSE:NES) +88%. Arena (NASDAQ:ARNA) +82%. BELLUS (NASDAQ:BLU) +56%. Foghorn Therapeutics (NASDAQ:FHTX) +43%. Petros Pharmaceuticals (NASDAQ:PTPI) +45%. Biofrontera (NASDAQ:BFRI) +29%. Mawson Infrastructure Group (OTCQB:MIGI) +17%. Reliance Global Grou...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GoPro (NASDAQ: GPRO ) stock is rising higher on Monday thanks to a new upgrade and price prediction from Wedbush analyst Alicia Reese. Source: Larry George II / Shutterstock.com Let’s start out with the u...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arena Pharmaceuticals (NASDAQ: ARNA ) stock is flying higher on Monday thanks to a huge deal with Pfizer (NYSE: PFE ). Source: Manuel Esteban / Shutterstock.com Pfizer signed a definitive agreement that ...
Gainers: Arena Pharmaceuticals (NASDAQ:ARNA) +84%, BELLUS Health (NASDAQ:BLU) +68%, Foghorn Therapeutics (NASDAQ:FHTX) +37%, Petros Pharmaceuticals (NASDAQ:PTPI) +27%, Tabula Rasa HealthCare (NASDAQ:TRHC) +23%. Losers: IGM Biosciences (NASDAQ:IGMS)...
Arena Pharmaceuticals (NASDAQ:ARNA) +90% on acquisition by Pfizer. Foghorn Therapeutics (NASDAQ:FHTX) +38% after collaborating with Lilly in oncology medicines. BELLUS Health (NASDAQ:BLU) +36% on positive BLU-5937 data in mid-stage chronic cough study. Petros Pha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday! Source: Eric Urquhart/Shutterstock.com We’ve got loads of pharmaceutical news to talk...
Proposed acquisition offers potentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases Expands innovative pipeline potentially enhancing growth through 2025 and beyond Transaction ...
High on Growth: Cannabis REITs are far-and-away the best-performing REIT sector of the past half-decade as the budding industry thrives in the murky and often contradictory regulatory framework of legalized marijuana. Joining Innovative Industrial, Power REIT, and AFC Gamma, a pair of...
Arena Pharmaceuticals (NASDAQ:ARNA) has achieved target enrollment in Study A of Phase 2/3 CULTIVATE trial evaluating the safety and efficacy of etrasimod, in participants with moderate to severe Crohn's disease (CD). CULTIVATE Study A reached target enrollment of 70 study participants to ass...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...